Individuals with NASH display low THR-β activity, which exacerbates mitochondrial dysfunction and lipotoxicity.35 Given the role played by THR-β signalling in liver metabolism, a strong rationale for developing THR-β-selective thyromimetics exists. The gene discussed is THRB; the disease is metabolic dysfunction-associated steatohepatitis.